NCT01543880View on ClinicalTrials.gov

Safety and Efficacy of Long-term Somatropin Treatment in Adults

CompletedOBSERVATIONAL

Enrollment

752

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

December 31, 2013

Study Completion Date

June 30, 2014

Conditions

Growth Hormone DisorderAdult Growth Hormone Deficiency

Interventions

DRUG

somatropin

Prescribed at the discretion of the treating physician according to product labelling

Trial Locations (1)

55127

Mainz

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY